FB1003
/ 4B Technologies
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 16, 2025
A Study of FB1003 in Healthy and Osteoarthritis Pain Subjects
(clinicaltrials.gov)
- P1 | N=64 | Recruiting | Sponsor: 4B Technologies Limited | Not yet recruiting ➔ Recruiting | Trial completion date: Jun 2025 ➔ May 2026 | Trial primary completion date: Jun 2025 ➔ Feb 2026
Enrollment open • Trial completion date • Trial primary completion date • Immunology • Musculoskeletal Pain • Osteoarthritis • Pain • Rheumatology
1 to 1
Of
1
Go to page
1